Malignant lymphoma of the lacrimal gland: A nation-based study

Archives of Ophthalmology

Volumn 129, Issue 10, 2011, Pages 1275-1280

  Rasmussen, Peter ^a   Ralfkiaer, Elisabeth ^b   Prause, Jan Ulrik ^a   Sjö, Lene D ^b   Siersma, Volkert D ^a   Heegaard, Steffen ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; INFORMATION PROCESSING; LACRIMAL GLAND DISEASE; LACRIMAL GLAND LYMPHOMA; LARGE CELL LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; DENMARK; EYE NEOPLASMS; FEMALE; HUMANS; LACRIMAL APPARATUS DISEASES; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053929676     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.270     Document Type: Article

References (27)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
2. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29(1):252-260.
3. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology. 2004;111(5):997-1008. (Pubitemid 38586697)
4. Sjö LD, Ralfkiaer E, Prause JU, et al. Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci. 2008;49(8):3283-3288.
5. Coupland SE, Hellmich M, Auw-Haedrich C, Lee WR, Stein H. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol. 2004;242(2):130-145. (Pubitemid 38324966)
6. Jenkins C, Rose GE, Bunce C, et al. Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Eye (Lond). 2003;17(7):809-820. (Pubitemid 37337033)
7. Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990;21(9):959-973. (Pubitemid 20308420)
8. Knop E, Knop N. The role of eye-associated lymphoid tissue in corneal immune protection. J Anat. 2005;206(3):271-285. (Pubitemid 40424847)
9. Dickinson AJ, Gausas RE. Orbital lymphatics: do they exist? Eye (Lond). 2006;20 (10):1145-1148. (Pubitemid 44515575)
10. Kíratlí H, Söylemezoǧlu F, Bilgiç S, Ruacan S. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 1999;15(4):272-276.
11. Lin YC, Kau HC, Kao SC, Hsu WM, Tsai CC. Systemically disseminated extranodal marginal zone B-cell lymphoma of lacrimal gland in a patient with systemic lupus erythematosus. Ophthal Plast Reconstr Surg. 2007;23(1):72-73.
12. Cassidy DT, McKelvie P, Harris GJ, Rose GE, McNab AA. Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjögren's syndrome. Orbit. 2005;24(4):257-263. (Pubitemid 41790951)
13. Farmer JP, Lamba M, Lamba WR, et al. Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis. Can J Ophthalmol. 2005;40(2):151-160. (Pubitemid 40676435)
14. Kao SC, Kau HC, Tsai CC, et al. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type. Am J Ophthalmol. 2007;143(2):311-316.
15. A predictive model for aggressive non-Hodgkin's lymphoma: the International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329(14):987-994.
16. Coupland SE, White V, Rootman J, et al. TNM staging of ocular adnexal lymphomas. In: Edge SE, Byrd DR, Garducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009:583-589.
17. Cheson BD, Pfistner B, Juweid ME, et al International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579-586. (Pubitemid 350002966)
18. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145(1):72-80. (Pubitemid 27009060)
19. Dunn P, Kuo TT, Shih LY, et al. Primary salivary gland lymphoma: a clinicopathologic study of 23 cases in Taiwan. Acta Haematol. 2004;112(4):203-208. (Pubitemid 39541266)
20. Kojima M, Shimizu K, Nishikawa M, et al. Primary salivary gland lymphoma among Japanese: a clinicopathological study of 30 cases. Leuk Lymphoma. 2007;48(9):1793-1798. (Pubitemid 47386715)
21. Vitali C, Bombardieri S, Jonsson R, et al European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-558. (Pubitemid 34539104)
22. Voulgarelis M, Moutsopoulos HM. Lymphoproliferation in autoimmunity and Sjögren's syndrome. Curr Rheumatol Rep. 2003;5(4):317-323.
23. Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore). 2009;88(5):284-293.
24. Andersen NS, Jensen MK, de Nully Brown P, Geisler CH. A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors. Eur J Cancer. 2002;38(3):401-408. (Pubitemid 34121968)
25. Rasmussen P, Sjö LD, Prause JU, Ralfkiaer E, Heegaard S. Mantle cell lymphoma in the orbital and adnexal region. Br J Ophthalmol. 2009;93(8):1047-1051.
26. Madge SN, McCormick A, Patel I, et al. Ocular adnexal diffuse large B-cell lymphoma: local disease correlates with better outcomes. Eye (Lond). 2010;24(6):954-961.
27. Sjö LD, Heegaard S, Prause JU, Petersen BL, Pedersen S, Ralfkiaer E. Extranodalmarginal zone lymphoma in the ocular region: clinical, immunophenotypical, and cytogenetical characteristics. Invest Ophthalmol Vis Sci. 2009;50(2):516-522.